Myofibroblast differentiation: Plasma membrane microdomains and cell phenotype

Experimental Nephrology

Volumn 10, Issue 5-6, 2002, Pages 313-319

  Schelling, Jeffrey R ^a   Sinha, Sumita ^a   Konieczkowski, Martha ^a   Sedor, John R ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Caveoli; Cell phenotype; Cytoarchitecture; Focal adhesions; Glomerulosclerosis; Glomerulus; Lipid rafts; Mesangial cell; Myofibroblast differentiation; Plasma membrane microdomains

Indexed keywords

CYTOSKELETON PROTEIN;

CELL DIFFERENTIATION; CELL MEMBRANE; DISEASE COURSE; EXTRACELLULAR MATRIX; HYPOTHESIS; INTRACELLULAR SPACE; KIDNEY CELL; KIDNEY DISEASE; MOLECULE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE; FIBROBLASTS; HUMANS; KIDNEY DISEASES; MEMBRANE MICRODOMAINS; MUSCLE, SMOOTH; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 0036971958     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065309     Document Type: Short Survey

References (49)

1. Johnson RJ: The glomerular response to injury: Progression or resolution. Kidney Int 1994;45:1769-1782.
2. Sedor JR, Konieczkowski M, Huang S, Gronich JH, Nakazato Y, Gordon G, King CH: Cytokines, mesangial cell activation and glomerular injury. Kidney Int 1993;39:S65-S70.
3. Border WA, Noble NA, Languino LR: Mechanisms of tissue injury and repair; in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney. Boston, Little, Brown, 1997, pp 1557-1578.
4. Sappino AP, Schurch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeleton proteins as marker of phenotype modulation. Lab Invest 1990;63:144-161.
5. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998;101:1827-1834.
6. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 2000;15:290-301.
7. Eddy AA: Role of cellular infiltrates in response to proteinuria. Am J Kidney Dis 2001;37:S25-S29.
8. Strutz F, Okada H, Lo C, Danoff TM, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
9. 1. J Cell Biol 1998;142:873-881.
10. Desmouliere A, Darby I, Costa AM, Raccurt M, Tuchweber B, Sommer P, Gabbiani G: Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 1997;76:765-778.
11. Galbiati F, Razani B, Lisanti MP: Emerging themes in lipid rafts and caveolae. Cell 2001;106:403-411.
12. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA: Focal adhesion kinase: A regulator of focal adhesion dynamics and cell movement. Oncogene 2000;19:5606-5613.
13. Critchley DR: Focal adhesions - The cytoskeletal connection. Curr Opin Cell Biol 2000;12:133-139.
14. Boudreau J, Jones PL: Extracellular matrix and integrin signalling: The shape of things to come. Biochem J 1999;339:481-488.
15. Jones PL, Schmidhauser C, Bissell MJ: Regulation of gene expression and cell function by extracellular matrix. Crit Rev Eukaryot Gene Expr 1993;3:137-154.
16. Ingber DE, Folkman J: How does extracellular matrix control capillary morphogenesis? Cell 1989;58:803-805.
17. Chicurel ME, Chen CS, Ingber DE: Cellular control lies in the balance of forces. Curr Opin Cell Biol 1998;10:232-239.
18. Chicurel ME, Singer RH, Meyer CJ, Ingber DE: Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature 1998;392:730-733.
19. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM: Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J Cell Biol 1996;135:1633-1642.
20. MacGillivray MK, Cruz TF, McCulloch CAG: The recruitment of the interleukin-1 (IL-1) receptor-associated kinase (IRAK) into focal adhesion complexes is required for IL-1β-induced ERK activation. J Biol Chem 2000;275:23509-23515.
21. Singh R, Wang B, Shirvaikar A, Khan S, Kamat S, Schelling JR, Konieczkowski M, Sedor JR: The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 1999;103:1561-1570.
22. Luo L, Cruz T, McCulloch CA: Interleukin-1-induced calcium signalling in chondrocytes requires focal adhesions. Biochem J 1997;324:653-658.
23. Yamada KM, Geiger B: Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 1997;9:76-85.
24. Abedi H, Zachary I: Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997;272:15442-15451.
25. Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science 2001;294:1708-1712.
26. Wu CY, Dedhar S: Integrin-linked kinase and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001;155:505-510.
27. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
28. + exchanger 3 (NHE3) is present in lipid rafts in the rabbit ileal brush border: A role for rafts in trafficking and rapid stimulation of NHE3. J Physiol 2001;537:537-552.
29. Villalba M, Bi K, Rodriguez F, Tanaka Y, Schoenberger S, Altman A: Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J Cell Biol 2001;155:331-338.
30. Feng X, Gaeta ML, Madge LA, Yang JH, Bradley JR, Pober JS: Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem 2001;276:8341-8349.
31. 2 rafts. EMBO J 2001;20:4332-4336.
32. Razani B, Lisanti MP: Caveolins and caveolae: Molecular and functional relationships. Exp Cell Res 2001;271:36-44.
33. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP: Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999;19:7289-7304.
34. Sowa G, Pypaert M, Sessa WC: Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 2001;98:14072-14077.
35. Dufour S, Beauvais-Jouneau A, Delouvée A, Thiery JP: Differential function of N-cadherin and cadherin-7 in the control of embryonic cell motility. J Cell Biol 1999;146:501-516.
36. Chapman HA, Wei Y, Simon DI, Waltz DA: Role of urokinase receptor and caveolin in regulation of integrin signaling. Thromb Haemost 1999;82:291-297.
37. Leitinger B, Hogg N: The involvement of lipid rafts in the regulation of integrin function. J Cell Sci 2002;115:963-972.
38. Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 1998;94:625-634.
39. Kerjaschki D: Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001;108:1583-1587.
40. Morioka Y, Koike H, Ikezumi Y, Ito Y, Oyanagi A, Gejyo F, Shimizu F, Kawachi H: Podocyte injuries exacerbate mesangial proliferative glomerulonephritis. Kidney Int 2001;60:2192-2204.
41. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-858.
42. Allen PG, Shuster CB, Kas J, Chaponnier C, Janmey PA, Herman IM: Phalloidin binding and rheological differences among actin isoforms. Biochemistry 1996;35:14062-14069.
43. Koukouritaki SB, Tamizuddin A, Lianos EA: Enhanced expression of the cytoskeleton-associated proteins paxillin and focal adhesion kinase in glomerular immune injury. J Lab Clin Med 1999;134:173-179.
44. Guo L, Sanders PW, Woods A, Wu C: The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 2001;159:1735-1742.
45. Tamai O, Oka N, Kikuchi T, Koda Y, Soejima M, Wada Y, Fujisawa M, Tamaki K, Kawachi H, Shimizu F, Kimura H, Imaizumi T, Okuda S: Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int 2001;59:471-480.
46. Fine LG: Caveolar cohabitation. Kidney Int 2001;59:797-798.
47. Laufs U, Liao JK: Targeting Rho in cardiovascular disease. Circ Res 2000;87:526-528.
48. Khwaja A, Connolly JO, Hendry BM: Prenylation inhibitors in renal disease. Lancet 2000;355:741-744.
49. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC: In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000;6:1362-1367.